Prediction of chemotherapeutic response by technetium 99m–MIBI scintigraphy in breast carcinoma patients
✍ Scribed by Yuuki Takamura; Yasuo Miyoshi; Tetsuya Taguchi; Shinzaburo Noguchi
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 165 KB
- Volume
- 92
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. Mammographic and physical examination assessments of the response of locally advanced breast carcinoma (LABC) to neoadjuvant therapy have been shown to be inaccurate. The authors studied the feasibility and accuracy of [technetium 99m]-sestamibi (MIBI) for monitoring the response of
## Abstract Collagen gel droplet embedded culture‐drug sensitivity test (CD‐DST) is the newly developed __in vitro__ chemosensitivity test that has several advantages over the conventional ones. The aim of the present study is to examine the clinical usefulness of this test in the prediction of res
## BACKGROUND. Various prognostic markers for lung carcinoma have been proposed, but to the authors' knowledge none is noninvasive and convenient for clinical use. The current study examined the utility of several radiotracers for the prediction of multidrug resistance (MDR) and radioresistance in
## Abstract The aim of this study was to assess the predictive power of ^99m^Tc‐MIBI scintigraphy performed in the middle of chemotherapy, for the final tumor response to chemotherapy, and compare it to that of ^201^Tl in malignant bone and soft tissue tumors (MBST). Sixty‐eight patients with MBST